Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Arm access showdown: which method is safer for artery procedures?

NCT ID NCT07573644

Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two methods of accessing the brachial artery in the arm for treating blocked leg arteries: a needle poke through the skin (percutaneous) versus a small cut (open). About 246 adults will be randomly assigned to one method. The goal is to see which approach causes fewer complications at the access site.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this trial succeeds, it could help doctors choose the safer method for accessing the brachial artery during endovascular procedures, potentially reducing complications.
What could go wrong
This is an early-stage comparative study with no direct treatment benefit. Results may not apply to all patients or settings, and complication rates could vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 246 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Endovascular diagnostic or therapeutic procedure via the brachial approach compatible with a 5F to 7F introducer * Patient affiliated with a social security scheme Exclusion Criteria: * Adult patient under legal guardianship or curatorship * Contraindication to endovascular treatment * History of brachial artery puncture within the past 1 month * History of open surgical approach at the elbow * Presence of a stent at the puncture site * Acute upper limb ischemia * Life expectancy of less than one month * Patient refusal to participate in the study * Allergy to aspirin or clopidogrel * Pregnant woman * Patients not speaking the French language, refusing or unable to comply with the follow-up proposed in the study * Requirement for another endovascular procedure or open surgery within 30 days following the BRAVO study procedure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endovascular surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endovascular surgery Endovascular treatments Peripheral arterial

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    11 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH de Cholet

    Cholet, 49309, France

  • CH de Saint Brieuc

    Saint-Brieuc, 22000, France

  • CHD La Roche-sur- Yon

    La Roche-sur-Yon, 85000, France

  • CHU Bordeaux

    Bordeaux, 33000, France

  • CHU Brest

    Brest, 29200, France

  • CHU Nantes

    Nantes, 44008, France

  • CHU d'Angers

    Angers, 49100, France

  • CHU de Rennes

    Rennes, 35000, France

  • Clinique mutualiste porte de Lorient

    Lorient, 56100, France

  • Hôpital Paris Saint Joseph

    Paris, 75014, France

  • Hôpital privé des Côtes d'Armor

    Plérin, 22190, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.